Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma

04:14 EST 7 Dec 2013 | Nature Publishing

Original Article: Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma

NEXT ARTICLE

More From BioPortfolio on "Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story